Vistagen Therapeutics, Inc.
VTGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001411685
No open-market purchases or sales by Vistagen Therapeutics, Inc. insiders were filed in the last 90 days; 48 institutions reported holding it in 13F filings for Q2 2026, worth $2.54M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Vistagen Therapeutics, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 86 | 1 | 83 | −2 |
| Shares | 40.8M | 27.1K | 38.4M | −2.40M (−5.9%) |
| Value | $4.15M | $2.79K | $4.79M | +$645.2K (+15.6%) |
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (12)
Institutions that held Vistagen Therapeutics, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Allspring Global Investments Holdings, LLC | 212,443 | $26.5K | 0.00% |
| Henrickson Nauta Wealth Advisors, Inc. | 200,000 | $24.9K | 0.02% |
| Johnson & Johnson | 190,494 | $23.8K | 0.01% |
| Captrust Financial Advisors | 109,190 | $13.6K | 0.00% |
| Neuberger Berman Group LLC | 67,530 | $8.42K | 0.00% |
| Moneta Group Investment Advisors LLC | 50,682 | $6.32K | 0.00% |
| Empower Advisory Group, LLC | 27,100 | $3.58K | 0.00% |
| Victory Capital Management Inc | 24,328 | $3.03K | 0.00% |
| Jackson Wealth Management, LLC | 23,850 | $2.97K | 0.00% |
| Panagora Asset Management Inc | 19,417 | $2.42K | 0.00% |
| Ameriprise Financial Inc | 10,865 | $1.35K | 0.00% |
| Russell Investments Group, Ltd. | 900 | $112 | 0.00% |
Sold out (14)
Institutions that held Vistagen Therapeutics, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Renaissance Technologies LLC | 104,800 | $11.0K |
| Millennium Management LLC | 107,494 | $11.0K |
| Exchange Traded Concepts, LLC | 83,230 | $8.57K |
| Balyasny Asset Management LLC | 81,769 | $8.42K |
| Two Sigma Advisers, LP | 33,500 | $3.45K |
| LPL Financial LLC | 32,000 | $3.30K |
| AQR Capital Management LLC | 10,392 | $1.07K |
| Atria Wealth Solutions, Inc. | 10,000 | $1.03K |
| Belvedere Trading LLC | 4,961 | $511 |
| Ellevest, Inc. | 321 | $33 |
| Credit Suisse AG | 8 | $1 |
| Clear Street Markets LLC | 100 | $0 |
| Nuveen Asset Management, LLC | 557,613 | – |
| IFP Advisors, Inc | 3,423 | – |
Not filed for Q1 2023 yet (1)
Institutions that held Vistagen Therapeutics, Inc. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Personal Capital Advisors Corp | 27,100 | $2.79K |